Contrary to some anecdotal reports, a new study has found semaglutide — the active ingredient in blockbuster weight loss drugs Ozempic and Wegovy — is not linked to increased risks of suicidal thoughts.
Read the full post on Becker's Hospital Review - Healthcare News